November 29 (SeeNews) - Bulgaria's Sopharma issued the following consolidated financial figures in a statement to the Bulgarian Stock Exchange (BSE):
9-mo 2009 9-mo 2008 |
Net profit/loss |
32,060,000 |
16,887,000 |
Minority Interest |
391,000 |
526,000 |
Pre-tax profit/loss |
36,187,000 |
19,582,000 |
Sales revenue |
350,604,000 |
345,036,000 |
Total revenue |
352,440,000 |
350,760,000 |
Total costs |
316,253,000 |
331,178,000 |
Total assets |
492,041,000 |
467,672,000 |
Capital |
132,000,000 |
132,000,000 |
(1 euro = 1.95583 Bulgarian levs)